Bio-Rad Laboratories Class B
BIO.B
5 hedge funds and large institutions have $5.98M invested in Bio-Rad Laboratories Class B in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
9% more capital invested
Capital invested by funds: $5.48M → $5.98M (+$498K)
0% less ownership
Funds ownership: 0.58% → 0.58% (-0%)
17% less funds holding
Funds holding: 6 → 5 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Armbruster Capital Management
Pittsford,
New York
|
-$4K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$972 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $4.46M | – | – | – |
|
2
Dimensional Fund Advisors
Austin,
Texas
| $1.28M | – | – | – |
|
3
Renaissance Technologies
New York
| $220K | – | – | – |
|
4
UBS Group
Zurich,
Switzerland
| $13K | – | – | – |
|
|
5
Bank of America
Charlotte,
North Carolina
| $1K | -$972 | -5 | -50% |
|
|
ACM
6
Armbruster Capital Management
Pittsford,
New York
| – | -$4K | -22 | Closed |
|
BIO.B Hedge Fund Activity: Q1 2017 in Review
5 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q1 2017, worth a combined $5.98M — up 9.1% from $5.48M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BIO.B and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Armbruster Capital Management, exiting entirely with an estimated $4K sold.
- 5 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q1 2017, down from 6 in Q4 2016.
- Funds reported $5.98M of Bio-Rad Laboratories Class B stock for Q1 2017, up 9.1% quarter-over-quarter.
- 0 funds opened new Bio-Rad Laboratories Class B positions in Q1 2017 and 1 closed out, a net change of -1 holder.
- The largest Bio-Rad Laboratories Class B seller in Q1 2017 was Armbruster Capital Management, an estimated $4K sold.
Based on aggregated 13F filings for Q1 2017.